Molecular heterogeneity and measurable residual disease of rare NPM1 mutations in acute myeloid leukemia: a nationwide experience from the GBMHM study group.
Elise FournierMaël HeibligChristine LespinassePascale Flandrin-GrestaAntoine GeayLaurent MiguetLaurène FenwarthLaurent VallatBrigitte SoubeyrandAlice Marceau-RenautAdriana PlesaClaude PreudhommePierre SujobertSandrine HayetteNicolas DuployezSarah HuetPublished in: Leukemia (2022)
Keyphrases